Cancers
Published by Multidisciplinary Digital Publishing Institute (MDPI)
eISSN : 2072-6694
Abbreviation : Cancers
Aims & Scope
Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology.
It publishes article types including Research Papers, Reviews, Editorials, Communications, etc.
Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.
The full experimental details must be provided so that the results can be reproduced.
There is, in addition, a unique feature of this journal: we accept studies showing meaningful but negative results.
While there are many journals that focus on cancer studies, none of them actively accepts negative results.
As a result, most negative data end up not being in the public domain even if the data were meaningfully negative and the study well designed.
By accepting those negative results, our journal encourages scientists to share those data so that they would not need to repeat the experiments that somebody else has already done.
We publish high-quality articles including basic, translational, and clinical studies on all tumor types.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2024 | 4.50 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 2503 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 87205 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.462 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 157 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.